Clinical trials in Liberec (Neclenene Mesto) – page 2

In Liberec, a large share of clinical research focuses on cardiovascular diseases, especially on preventing and treating acute myocardial infarction, heart failure, and stroke risk in people with atrial fibrillation or high overall cardiovascular risk.

• Testing new ways to reduce major adverse cardiovascular events
• Studying treatments for acute coronary syndrome and ST-elevation myocardial infarction
• Evaluating prevention strategies for stroke and systemic embolism
• Improving care for patients at elevated risk of heart attack or heart failure

These studies aim to strengthen prevention and improve treatment effectiveness in people with serious heart-related conditions.

Research in digestive system diseases centers on liver health, with studies in non-alcoholic steatohepatitis, alcohol-related liver disease, and cirrhosis.

• Testing therapies that may reduce liver fibrosis and improve liver function
• Exploring combinations aimed at better control of liver damage
• Assessing options for people with advanced chronic liver disease
• Studying treatment effects in metabolic and alcohol-related liver injury

The overall goal is to find better ways to slow liver damage and support long-term liver health.

Oncology trials in this city include studies of prostate cancer and bladder cancer, with attention to both localized and metastatic disease.

• Evaluating new treatment combinations for high-risk prostate cancer
• Studying therapies for metastatic castration-sensitive prostate cancer
• Testing approaches for high-risk non-muscle-invasive bladder cancer
• Looking for better disease control and longer progression-free survival

These studies focus on improving cancer outcomes while expanding treatment options for patients with difficult-to-treat disease.

Clinical trials in respiratory tract diseases address both chronic and acute conditions, including chronic obstructive pulmonary disease and acute respiratory distress syndrome.

• Testing therapies to reduce COPD flare-ups
• Studying treatments for severe breathing failure linked to infection
• Evaluating supportive options for former smokers with respiratory symptoms
• Improving outcomes in serious lung inflammation and infection-related illness

The research is aimed at easing symptoms, preventing complications, and improving lung function in high-need patients.

Trials in nutritional and metabolic diseases are mainly directed at obesity-related liver disease and metabolic complications that affect liver and cardiovascular health.

• Studying therapies that may improve metabolism and reduce liver injury
• Exploring treatment combinations for people with advanced liver fibrosis
• Assessing the impact of metabolic control on disease progression
• Supporting better management of complex long-term metabolic disorders

These studies aim to link metabolic treatment with broader benefits for liver and overall health.

Research in hemic and lymphatic diseases includes studies for hemophilia A and B, focusing on joint health and bleeding-related complications.

• Assessing joint status in people receiving preventive treatment
• Monitoring how therapy may protect mobility and reduce joint damage
• Supporting better long-term management of bleeding disorders
• Improving quality of life for patients with inherited clotting conditions

The research reflects a practical effort to preserve joint function and reduce the burden of recurrent bleeding.

Clinical research also covers musculoskeletal diseases, especially chronic non-specific low back pain, a common condition that can be difficult to manage when standard options do not provide enough relief.

• Testing new approaches for pain reduction
• Studying treatment response in people with persistent back pain
• Looking for alternatives when usual non-opioid care is not enough
• Evaluating ways to improve daily function and comfort

These studies are designed to support more effective and better-tolerated pain care.

In the area of virus diseases and infection-related care, trials include influenza prevention as well as microbiome-focused research in patients receiving antibiotics for Lyme borreliosis.

• Evaluating vaccine effectiveness in older adults
• Studying protection against seasonal influenza
• Examining how antibiotic use affects the gut microbiota
• Exploring supportive approaches during treatment for infection

The aim is to improve prevention and understand how infection treatments influence the body.